Andreessen Horowitz led the Series A round for the faith-based wellness app developer.
"When we first came up with the concept for Glorify, we knew we were onto something big, but as we met with investors, it soon became clear that we've managed to capture lightning in a bottle,"
The financing round was led by Talis Capital with participation from multiple angels and existing backers.
"We are delighted to have received such credible investor support to continue on our mission to empower and support those with cancer. It’s imperative that we start understanding how therapies are affecting patients: for pharmaceutical companies, our technology enables deeper patient understanding which leads to better drugs, greater differentiation and faster licensing, as well as the ability to provide personalised scalable support to patients. For patients, this means better care and improved outcomes from cancer. We’re now looking forward to applying our rich data and machine learning capabilities to novel predictive analytics to generate even richer insights for our life science partners."
The Series A round was led by Calculus Capital and brings total funding to over £6m.
"In the last 18 months the world has seen the positive impact of video in recruitment as it helps to improve diversity, the candidate experience and time to hire."
The London-based biotechnology firm raised the capital from backers including Cantos Ventures and Y Combinator.
"The global pandemic has catapulted RNA therapeutics into the mainstream, yet the field is constrained to targeting the liver. Sixfold’s iterative platform technology and use of machine learning will unlock the power of mRNA and RNAi for many diseases across various tissue types. We are delighted to support the Company in this seed round and look forward to their rapid progress over the coming years."